Cannabis Use and its Association with Psychological Disorders.
Urits I, Gress K, Charipova K, Li N, Berger AA, Cornett EM, Hasoon J, Kassem H, Kaye AD, Viswanath O.
Psychopharmacol Bull. 2020 May 19;50(2):56-67.
Tusi: a new ketamine concoction complicating the drug landscape.
Palamar JJ.
Am J Drug Alcohol Abuse. 2023 Sep 3;49(5):546-550. doi: 10.1080/00952990.2023.2207716. Epub 2023 May 10.
The role of sphingolipids in psychoactive drug use and addiction.
Kalinichenko LS, Gulbins E, Kornhuber J, Müller CP.
J Neural Transm (Vienna). 2018 Apr;125(4):651-672. doi: 10.1007/s00702-018-1840-1. Epub 2018 Jan 10.
Timing of alcohol and other drug use.
Martin CS.
Alcohol Res Health. 2008;31(2):96-9.
Intercorrelation of Alcohol and Other Drug Use Disorders among a National Sample of Drivers.
Scherer M, Canham S, Voas RB, Furr-Holden CD.
J Psychoactive Drugs. 2018 Apr-Jun;50(2):143-150. doi: 10.1080/02791072.2017.1366605. Epub 2017 Aug 28.
How toxic is ibogaine?
Litjens RP, Brunt TM.
Clin Toxicol (Phila). 2016;54(4):297-302. doi: 10.3109/15563650.2016.1138226. Epub 2016 Jan 25.
Intended and unintended use of cathinone mixtures.
Guirguis A, Corkery JM, Stair JL, Kirton SB, Zloh M, Schifano F.
Hum Psychopharmacol. 2017 May;32(3). doi: 10.1002/hup.2598.
Alcohol and other drug use among Belgian workers and job-related consequences.
Lambrechts MC, Vandersmissen L, Godderis L.
Occup Environ Med. 2019 Sep;76(9):652-659. doi: 10.1136/oemed-2019-105690.
Role of cannabinoids in alcohol-induced neuroinflammation.
García-Baos A, Alegre-Zurano L, Cantacorps L, Martín-Sánchez A, Valverde O.
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jan 10;104:110054. doi: 10.1016/j.pnpbp.2020.110054. Epub 2020 Aug 3.
Development and validation of the Substance Use Protective Strategies Scale (SUPSS) among Polish young adults using various psychoactive substances.
Greń J, Richards DK, Pearson MR, Ostaszewski K.
Int J Drug Policy. 2023 Oct 5:104216. doi: 10.1016/j.drugpo.2023.104216. Online ahead of print.
